Katharina Fink

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (7)

Joachim Burman

Uppsala University

SWEDEN

View details

Hanna Gyllensten

Karolinska Institutet

SWEDEN

View details

Fredrik Piehl

Karolinska Institutet

SWEDEN

View details

Anders Svenningsson

Karolinska Institutet

SWEDEN

View details

Jonatan Salzer

Lecturer, Consultant neurologist

Umeå University

SWEDEN

View details

Jan Lycke

Consultant/Professor

Sahlgrenska universitetssjukhuset

SWEDEN

View details

Roberto Furlan

Vita-Salute San Raffaele University

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katharina Fink

Research Interests

Explore related searches

Contact this professor

Articles (10)

Recent trends in disease-modifying therapy use and associated sickness absence and disability pension among people with multiple sclerosis in Sweden

Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study

COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab.

Incidence rate and prevalence of pediatric‐onset multiple sclerosis in Sweden: A population‐based register study

Rituximab treatment in pediatric‐onset multiple sclerosis

Granulocyte Activation and Astrocyte Damage Markers in CSF Differentiate Acute NMOSD and MOGAD from MS (P9-14.004)

Self‐reported restrictions in different life domains and associated factors among people with multiple sclerosis in Sweden

Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis

Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy

Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study

Collaborators (7)

Joachim Burman

Hanna Gyllensten

Fredrik Piehl

Anders Svenningsson

Jonatan Salzer

Jan Lycke

Roberto Furlan

Make your next move.